BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17258335)

  • 1. How should we cost ICD therapy?
    Fox DJ; Davidson NC; Fitzpatrick AP
    Int J Cardiol; 2007 May; 118(1):1-3. PubMed ID: 17258335
    [No Abstract]   [Full Text] [Related]  

  • 2. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
    Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of implantable defibrillators: perceptions and reality.
    Camm J; Klein H; Nisam S
    Eur Heart J; 2007 Feb; 28(4):392-7. PubMed ID: 16887857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of implantable cardioverter-defibrillators.
    Boriani G; Biffi M; Martignani C; Gallina M; Branzi A
    Eur Heart J; 2001 Jun; 22(12):990-6. PubMed ID: 11428834
    [No Abstract]   [Full Text] [Related]  

  • 5. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
    Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICD for primary prophylaxis of sudden cardiac death: an Indian perspective.
    Naik N; Juneja R
    J Assoc Physicians India; 2007 Apr; 55 Suppl():47-53. PubMed ID: 18376491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary prevention of sudden death - afraid of the truth].
    Klein H
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2113. PubMed ID: 12397556
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of implantable cardioverter-defibrillators in Brazil: primary prevention analysis in the public sector.
    Ribeiro RA; Stella SF; Camey SA; Zimerman LI; Pimentel M; Rohde LE; Polanczyk CA
    Value Health; 2010; 13(2):160-8. PubMed ID: 19725912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
    Tung R; Zimetbaum P; Josephson ME
    J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of the implantable cardiodefibrillator (ICD) in the prevention of sudden death. Results of evidence based medicine].
    González CM
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-44-S2-46. PubMed ID: 17972377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioverter defibrillators in primary prevention of sudden cardiac death: a cost or an investment?
    Boriani G
    Value Health; 2007; 10(1):1-2. PubMed ID: 17261110
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of the implantable cardioverter defibrillator.
    Hlatky MA; Sanders GD; Owens DK
    Card Electrophysiol Rev; 2003 Dec; 7(4):479-82. PubMed ID: 15071279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death: opportunities for prevention.
    Morgan JM; Cowan JC; Camm AJ; McComb JM
    Heart; 2006 Jun; 92(6):721-3. PubMed ID: 16159972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness in a flat world--can ICDs help the United States get rhythm?
    Goldman L
    N Engl J Med; 2005 Oct; 353(14):1513-5. PubMed ID: 16207856
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sudden death. Implantable defibrillators. Value of the technology and economic impact].
    Jazra C
    J Med Liban; 1999; 47(5):301-3. PubMed ID: 10887533
    [No Abstract]   [Full Text] [Related]  

  • 17. The high cost of implantable defibrillators.
    Hlatky MA; Mark DB
    Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should the implantable cardiac defibrillator be used for primary prevention of sudden death? A review of the issues relevant to hospital decision making.
    McGregor M; Chen J
    Can J Cardiol; 2004 Oct; 20(12):1199-204. PubMed ID: 15494771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators for primary prevention of sudden death in heart failure: are there enough bangs for the bucks?
    Stevenson LW
    Circulation; 2006 Jul; 114(2):101-3. PubMed ID: 16831996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.